Thus, the rate of data-driven behaviour change p(t) can be defined as p(t) = news(t) = news(t) , max{news(t), t ‚àà NT} t ‚àà NT = {1, ‚Ä¶ , 38}, then we obtain the rate of behaviour change in the Shaanxi province of China during the 2009 A/H1N1 influenza epidemic from September 3 to October 10 (the first wave), which together with new hospital notifications has been used to estimate all unknown parameters (OR0, OR1, OR2, OR3, OR4, ÔøΩÔøΩÔøΩÔøΩÔøΩÔøΩ, ÔøΩÔøΩÔøΩÔøΩÔøΩÔøΩ, ÔøΩÔøΩÔøΩÔøΩÔøΩÔøΩ, ÔøΩÔøΩÔøΩÔøΩÔøΩÔøΩ, ÔøΩÔøΩÔøΩÔøΩÔøΩÔøΩ) of Equation 6. We took account of agent heterogeneity by allowing each individual parameter to vary across a distribution (ie, the same mean but different standard deviation), from which agents sampled their values using log-normal distributions for the ORk(k = 0, 1, ‚Ä¶ , 4) (ie, ORk ‚àº exp{N(ÔøΩÔøΩÔøΩÔøΩÔøΩÔøΩ, ÔøΩÔøΩÔøΩÔøΩÔøΩÔøΩ2)}) and normal distributions for ÔøΩÔøΩÔøΩÔøΩÔøΩÔøΩ, ÔøΩÔøΩÔøΩÔøΩÔøΩÔøΩ, ÔøΩÔøΩÔøΩÔøΩÔøΩÔøΩ, ÔøΩÔøΩÔøΩÔøΩÔøΩÔøΩ, and ÔøΩÔøΩÔøΩÔøΩÔøΩÔøΩ.The proposed iSEIR model is shown as in Figure II_iSEIR model Illustration below: pij qjk ‚àëSi ‚àëEj ‚àëIk
In order to make the system (3) short and analyze easily, we use the following denotation: ÔÉ• ÔÉ• ÔÉ• ÔÉ• ÔÉ•ÔÉ¨ÔÅ≠ ÔÄΩ ÔÉØ i ÔÅ≠i; ÔÅ•= i iÔÅ•; ÔÅ°ÔÄΩ j j ÔÅ°; ÔÄΩÔÅ¢ j j ;ÔÅ¢ ÔÄΩÔÅ¨ k k ÔÉ≠ ÔÉØ p ÔÄΩ ÔÉ• ÔÉ• pij;q ÔÄΩ ÔÉ• ÔÉ• q jk ÔÉÆ ij jk ÔÅ¨
As our iSEIR model is based on the framework of multiplex networks, we also give some notations here, more in details are given in [28] (also see notations‚Äô specification listed for the simulations based on iSEIR given by Appendix I below).2 The first case of respiratory disease caused by a novel coronavirus was identified in
3 Wuhan City, Hubei Province, China in In December 2019 and on 13 January 2020 the 4 first case outside of China was reported in Thailand.1 On 11th March 2020 the World
5 Health Organization named it coronavirus disease 2019 (COVID-19) and considered as 6 pandemic.2 The first case appeared in Egypt on 14th February 2020 for a foreigner and 7 fortunately was asymptomatic until 1st of March 2020 he was the only reported case after 8 that few cases started to appear till 14th March 2020 to reach 110 cumulatively, and thenDescription total population (initally) percentage of initially immune persons number of initially infectious persons percentage of contagiousness of prodromal vs. later infectious states current reproduction number, average R0 average, Rvar amplitude
R(t) = R0 ‚àí sin(0.0172 ‚àó (t ‚àí c)) ‚àó Rvar (25) with c being the shift in time dependent on the simulation start dateContact tracing by Public Health staff Quarantine centers for overseas returnees and domestic contacts of confirmed cases
24hrs desk for public complaints at President Secretariat Sensitize the public to their active role in the response, Trace every contact, self-quarantine & surveillance
National Action Committee to prevent the spread of Corona virus disease in Sri Lanka established
National Operation Center for Prevention of COVID-19 established All taxes waived for imported masks and hand sanitizers Suspension of importation of motor vehicles and non-essential goods for 3 months Special task force - effectively/efficiently regulate distribution of essential commodities COVID ‚Äì 19 Healthcare and Social Security Fund‚Äô established Compulsory face mask in publicmacroeconomic impact of the epidemic and Ke > 0, Kh > 0, ¬µ > 0 some constants (parameters) defined below, implementing the desired tradeoff amounts to fixing Œ± to a given value and to find a solution to the following optimization problem (OP): minimize u Œ±Ke +
T + (1 ‚àí Œ±)Kh [s(0) ‚àí s(T )] subject to ‚àÄt ‚àà [0, T ], œÉN i(t) ‚â§ NmICaUx Equations (1) and (2) where: ‚Ä¢ Ke > 0 and Kh > 0 are constants that weight the economic and health cost functions (they act as conversion factors allowing one to obtain appropriate units and orders of magnitude); ‚Ä¢ œÑ0 and œÑ1 respectively represent the lockdown starting time and duration; ‚Ä¢ the parameter ¬µ ‚â• 1 accounts for possible differences in terms of economic impact between the lockdown and after-lockdown phases; ‚Ä¢ s(0) and s(T ) are respectively the fractions of the population infected at the beginning and the end of the analysis.Note that if pH is the probability that a given infected individual is admitted to a hospital at some point, and if DH is the interval between the time of infection and hospital admission, then, the cumulative number of hospitalized patients at time t ‚â• 0, denoted by ŒõH(t), is given by
As a result, one can obtain the probability of being admitted to hospital if one knows f and the distributions of D and DH through the relation, pH = f
ŒõH (t)E e‚àíœÅD ŒõD(t)E [e‚àíœÅDH ] , for any time t ‚àà [0, tL] for which D < t and DH < t almost surely, where tL is the time at which lockdown measures are put into place.4.2 The iSEIR model as a tool to predict that ‚Äúthe COVID-19 situation in China would peak around mid- to late February 2020‚Äù on February 10, 2020.
Using the concept of Turning Phase and the application of the iSEIR model on February 10, 2020, based on 3 weeks of available daily data (from Jan. 23, 2020 to Feb. 10,2020) released by NHC of China, our simulation successfully modeled the future pattern of official data released almost 3 weeks later, as shown by the conclusion below (the reports from [29]-[30], the corresponding simulations‚Äô inputs by applying iSERI model given by Appendix I with incorporation of the official data released by NHC of China as of Feb. 10, 2020).4, right-hand panels) all fall within the 95% projection interval of 0% and 10% seasonality until late August 2021; while the assumption of 10% seasonality leads to an excellent agreement between the median prediction and the hospital data prior to the peak in late July 2021. The median deaths are again an overestimate, likely due to improvements in medical treatments that were applied as we progressed through 2021. In addition, we included in later Roadmaps a correlation between the mortality risk and hospital occupancy, meaning smaller waves in the summer of 2021 would be associated with relatively lower deaths than the major wave of January 2021.Early Illness dPresence of two or more of the following features: fever (might be subjective), chills, rigors, myalgia, headache, diarrhea, sore throat or rhinorrhea
Mild-to-Moderate Respiratory Illness dTemperature of > 100.4 F (> 38 C); and dOne or more clinical findings of respiratory illness (for example, cough, shortness of breath, difficulty breathing)
Meets clinical criteria of mild-to-moderate respiratory illness and one or more of the following findings: dRadiographic evidence of pneumonia; dRespiratory distress syndrome; dAutopsy findings consistent with pneumonia or respiratory distress syndrome without an identifiable cause
One or more of the following exposures in the 10 days before the onset of symptoms: dTravel to a foreign or domestic location with documented or suspected recent transmission of SARS-CoV; dClose contact‚Ä† with a person with mild-to-moderate or severe respiratory illness and history of travel in the 10 days before onset of symptoms to a foreign or domestic location with documented or suspected recent transmission of SARS-CoVBy applying the system (13), we establish the necessary conditions for the optimality of the granular FOCP: (i) The state system ‚éßC Œ≤ ‚é™ ‚é®C0+ DŒ≤ Q(S(t ) ) = bQ(N (t ) ) ‚àí dQ(S(t ) ) ‚àí cQ(S(t ) )Q(I (t ) ) ‚àí Q(u(t ) )Q(S(t ) )
0+ D Q (E (t ) ) = cQ (S (t ) )Q (I (t ) ) ‚àí (e + d )Q (E (t ) )
C Œ≤ ‚é™ ‚é©C0+ DŒ≤ Q(I (t ) ) = eQ(E (t ) ) ‚àí (r + a + d )Q(I (t ) )
Q(N (t ) ) = (b ‚àí d )Q(N (t ) ) ‚àí aQ(I (t ) ), (ii) The co-state system ‚éß  S ~ ~ sCynEtax into GIS for niodelling urban spaces,l r ~ k r r i n r i ~ i i d [6] Jin, G. J.. 2001, Introduction to Urbnn Design Guidelines in USA, Ur*DirriPlrvrriiirig O!wrerrs, 2: 6-10.Bayesian network analysis of Covid-19 data reveals higher infection prevalence rates and lower fatality rates than widely reported
To cite this article: Martin Neil, Norman Fenton, Magda Osman & Scott McLachlan (2020): Bayesian network analysis of Covid-19 data reveals higher infection prevalence rates and lower fatality rates than widely reported, Journal of Risk Research, DOI: 10.1080/13669877.2020.1778771 To link to this article: https://doi.org/10.1080/13669877.2020.1778771
Published online: 29 Jun 2020. Submit your article to this journal Article views: 590 View related articles View Crossmark data
Bayesian network analysis of Covid-19 data reveals higher infection prevalence rates and lower fatality rates than widely reported
Martin Neila,b , Norman Fentona,b , Magda Osmanc and Scott McLachlana aSchool of Electronic Engineering and Computer Science, Queen Mary University of London, London, UK; bAgena Ltd, Cambridge, UK; cBiological and Experimental Psychology Group, Mary University of London, London, UKWe begin by defining the set of feasible NPIs, as described in the optimization problem (4), which, for each state x, is defined as:
We note that, because the input-to-peak of hospitalization map H(u; x) is parametrized by the instantaneous state of the system x, the set Ux is also parametrized by x. When the set Ux is (point-wise in time) convex, a suitable control function t ‚Üí u(t) can be obtained as a solution of the following dynamical system: uÀô = PUx u ‚àí Œ∑(‚àÇœÜ(u) + ‚àÇuF (u)‚àÇœà(ƒ±)) ‚àí u, where Œ∑ > 0 is a tunable parameter of the controller, and PUx denotes the Euclidean projection operator, namely, given z ‚àà Rn and a convex set U ‚äÜ Rn,being susceptible to be infected by the SARS-Cov2 virus, the fraction having been exposed to it, the fraction infected, and the fraction removed (including recoveries and deceases), the epidemic is assumed to obey the following continuous-time dynamics: Ô£± Ô£¥Ô£¥Ô£¥Ô£¥Ô£¥Ô£¥Ô£¥Ô£¥Ô£¥Ô£¥Ô£¥Ô£¥Ô£¥Ô£¥Ô£¥Ô£¥Ô£¥Ô£≤ ds dt (t) de dt (t) = ‚àíŒ≤(t)i(t)s(t) = Œ≤(t)i(t)s(t) ‚àí Œ≥e(t) Ô£¥Ô£¥Ô£¥Ô£¥Ô£¥Ô£¥Ô£¥Ô£¥Ô£¥Ô£¥Ô£¥Ô£¥Ô£¥Ô£¥Ô£¥Ô£¥Ô£¥Ô£≥ di dt (t) dr dt (t) = Œ≥e(t) ‚àí Œ¥i(t) = Œ¥i(t) s(t) + e(t) + i(t) + r(t) = 1 where: ‚Ä¢ Œ≤(t), t ‚àà R, represents the time-varying virus transmission rate; ‚Ä¢ Œ≥ denotes the rate at which the exposed subject develops the disease (this includes people presenting symptoms and asymptomatics).2.2. Concept introduction take home points  We are currently too slow to comprehensively respond to emerging and re-emerging outbreaks  Biosurveillance in high risk areas needs to be bolstered with deployment of sustainable diagnostic platforms and datasharing capabilities  Effective collaboration is key to successful biopreparedness and response  Shared understanding of the situation0s gravity and effective communication of the same among stakeholders is essential  Preparedness can be improved in many areas to include: standardizing animal models; leveraging vaccine construct platforms; growing clinical trials capabilities in high risk areas; leveraging and expanding global biomanufacturing capabilities; developing and deploying analytic assays; and streamlining regulatory pathways.V no vaccine linear, no r or linear with linear with , r Holling type 3 days
Figure 7. Comparison of vaccination models for two scenarios, both with Œ≥ = 0.1, Œ∑ = 0.2, R0 = 3, R(0) = 0.3, I(0) = 0.1, E(0) = 0.05, and best fit values for r and K; the top panels assume best fit values for œï and œÑ, while the latter assume twice the best-fit values for œï and 30 days for œÑ. The left panels show the fraction of the population that has been vaccinated, the middle panels show the current fraction that is infected, and the right panels show the cumulative fraction infected.The model still assumed that each Step would lead to a discrete change in the level of precautionary behaviour estimated at 55% of the value at the end of the third lockdown in early March 2021 for Step 3 and 15% for Step 4. This can be translated into R excluding immunity: Step 1 Rei = 1.66 (CI 1.42 ‚àí 1.83); Step 2 Rei = 1.88 (CI 1.64 ‚àí 2.10); Step 3 Rei = 2.41 (CI 2.25 ‚àí 2.57); and Step 4 Rei = 3.51 (CI 3.31 ‚àí 3.71) - with Steps 1 and 2 informed by the most recent data.Symbol Œ≤ Œª Œ∏ Œ¥ œÉ Œ∑ Œ≥ Œ∫i‚Üíh Œ∫i‚Üíd Œ∫h‚Üíd œÅ y ŒΩ Npop
Description transmission rate difference in infectiousness symptomatic/asymptomatic probability of vaccinating an individual in compartment s daily death/birth rate 1/duration of natural immunity 1/duration of vaccine immunity
1/latency period rate of recovery probability of hospitalization after infection probability of death after infection probability of death after hospitalization 1/hospitalization period vaccination rate vaccination efficacy state population size, CO, USA fraction of Susceptible on 03/01/21 fraction of Exposed on 03/01/21 fraction of Infected on 03/01/21 fraction of Hospitalized on 03/01/21 fraction of Recovered on 03/01/21 fraction of Vaccinated on 03/01/21 level of lockdown on 03/01/21P: healthcare workers (defined as workers in a healthcare setting that could be exposed to a patient with acute respiratory illness) I: medical masks (defined surgical, procedural, isolation, laser, fluid resistant or face masks certified for use as a medical device) C: N95 respirators (defined as respirators were N95 filtering face piece respirators certified by the National Institute for Occupational Safety and Health (NIOSH) and European standard filtering face-piece (FFP2) respirators) O: viral respiratory infection laboratory confirmed by PCR, serology, or viral culture (our primary outcome), laboratory-confirmed coronavirus infection, laboratory-confirmed influenza infection, influenza-like illness, clinical respiratory illness, or workplace absenteeismThe rate of transmition of the disease to their household contacts were 26.1%, 9.8% and 0% in non-healthcare workers, healthcare workers infected before the use of protective equipments and healthcare workers infected after the use of protective equipments respectively, indicating that use of protective equipments, adhering to infection control precautions and early quarantine were effective in stopping transmission.19 A similar study in Singapore also found that HCWs had a lower rate of household transmission but that their secondary household transmission rate was higher (6.2%).20 Phasing of illnesses is probably the reason for a much higher transmission rate in healthcare facilities.The transmission and transition parameters are described below: Œ≤(t) = rate of infection due to contact at time t, œá = rate of infected from exposed population, œÜqh = rate of transition from quarantine to hospitalization, Œ≥as = rate of transition of asymptomatic population to symptomatic population, Œ¥ar = rate of recovery of asymptomatic infected individual, œÜsh = rate of transition of symptomatic population to hospitalization, Œ¥hr = rate of recovery of hospitalized individual, Œ∑ = death rate of the population, Œ≥sr = rate of recovery of symptomatic infected individual, Œ±1 = fraction part of œá from Ei to Qi class, Œ±2 = fraction part of œá from Ei to Ai class, Œ±3 = fraction part of œá from Ei to Ii class, q = control parameter for quarantined class.1 Regarding transmission rate (Œ≤) and Basic reproduction number (R0) researcher depended 2 on the published data available on GitHub , midas-network 9 , R0 for Egypt as published 3 2.3 and so Œ≤ =0.23 by applying the formula; ÔøΩÔøΩÔøΩÔøΩÔøΩÔøΩ
5 For the purpose of simulation different scenario of effective contacts during Ramadan, 6 different R0 and Œ≤ were used within the range of previous published data available on 7 midas-network.9
8 Starting from model1 (M1) that represent less effective contact rate than the current 9 situation (Œ≤ =0.22, R0=2.2) till model10 (M10) that represent higher effective contact rate 10 with Œ≤ =0.32 and R0=3.2Face mask with ear loops, green, 3-ply, nickel-free Materials- outer layer: PP (polypropylene non-woven) fabric-like - middle layer / filter: melt blown - outer layer: PP (polypropylene non-woven excellent filter performance > 99% BFE non sterile, lint-free, skin-friendly integrated nose bridge, adjustable anatomically Medical Face Mask Ear Loop 3 layer protective filtering ~ Anti-fog, Anti-droplet, Dust and Effective Filters bacterial ‚Ä¢ Inner Layer: Skin-Friendly and comfortable ‚Ä¢ Filter Layer: Filter oily and non-oily particles, antibacterial material ‚Ä¢ Outer Layer: Block larger particles ‚Ä¢ BFE=>95%
Material composition: Inner and outer premium polypropylene nonwoven fabric, Middle antibacterial filter layer, 3-layer thickened protection designBasic reproduction number, original variant Basic reproduction number, Alpha (B.1.1.7)-like variant Basic reproduction number, Delta (B.1.617.2)-like variant Effective reproduction number, original variant Average contact rate prior to the epidemic (individuals/day)
Probability of transmission per contact, original variant Alpha Probability of transmission per contact, Alpha-like variant Delta Probability of transmission per contact, Delta-like variant c Average contact rate of non-compliant individuals starting November 16, r1 Ratio between contact rates of compliant and non-compliant individuals r2 Ratio between contact rates of vaccinated and non-compliant individuals 1/Œ± Duration of latent period (days)
Duration of compliant state when there is no vaccination (days) Parameter describing how loss of compliance increases depending on vaccination coverage (1/day)Thus, we obtain         œÅ gr S(t ), S(t ) + œÅ gr I (t ), I (t ) + rœÅ gr I (t ), I (t )      ‚â§ (2cN0 + r ) œÅ gr S(t ), S(t ) + œÅ gr I (t ), I (t )        ‚â§ (2cN0 + r ) œÅ gr S(t ), S(t ) + œÅ gr I (t ), I (t ) + œÅ gr R(t ), R(t )
Dgr f (t, X (t )), f (t, X (t )) ‚â§ 2cN0  = (2cN0 + r )Dgr (X (t ), X (t )), which implies the hypothesis (HF2) holds with L1 = 2cN0 + r.The task was performed under the framework of the EFOP-3.6.1-16-2016-00011 project, "Rejuvenating and renewing University - Innovative City of Knowledge The Institutional Development of the University of Miskolc for Intelligent Specialization."1/day 1/day people people people people people people people estimated assumed assumed estimated equations dSi dt = ‚àíŒªiSi, dEi dt = ŒªiSi ‚àí Œ±iEi, dIir dt = œÅiŒ±iEi ‚àí ¬µiIir ‚àí Œ≥iIir, dIiu dt = (1 ‚àí œÅi) Œ±iEi ‚àí ¬µiIiu ‚àí Œ≥iIiu, dRi dt = Œ≥i (Iir + Iiu) , where Œªi is the force of infection, Œ±i is the latency rate, œÅi is the reporting rate, ¬µi is the death rate, and Œ≥i is the recovery rate, for a particular age group i. Table 2.1 lists the set of parameters, their descriptions and units, including initial values for the state variables of the three different age groups.Step 3. For each t ‚àà [0, T], the boundedness of f(t, X(t)) is implied from following estimation      
Dgr f (t, X (t )), 0 ‚â§ 2cœÅ gr S(t )I (t ), 0ÀÜ (t ) + rœÅ gr I (t ), 0ÀÜ      œÅ gr (S(t )I (t ), I (t ) ) + œÅ gr I (t ), 0ÀÜ (t ) + rœÅ gr I (t ), 0ÀÜ          ‚â§ 2c œÅ gr S(t ), 0ÀÜ (t ) œÅ gr I (t ), 0ÀÜ (t ) + œÅ gr I (t ), 0ÀÜ (t ) + rœÅ gr I (t ), 0ÀÜ ‚â§ N0 [r + 2c (N0 + 1 )].30 Keywords: Social Distancing Policy; COVID-19 Social Transmission Behavior; Policies and 31 Individual Behavior; Convergence and Stability Properties; Epidemiology Framework 32
35 As the COVID-19 epidemic is continuously demonstrating a growing pattern of 36 community transmission, even with effective social isolation (lockdown or voluntarily shelter in 37 place) and COVID-19 testing policies, theoretical analysis was performed to track the main 38 transmission pattern of the virus reproductive behavior under other unsuspected forms of 39 transmission (atmospheric) within social distancing policy and its infectious disease modeling 40 concerning methodological aspects in the geographical regions samples of Asia, South America, 41 North America, Middle East, Africa and European countries.To identify and collate global experience, practice and recommendations relating to OR practice in the context of the COVID19 pandemic
To evaluate the effect of powered air-purifying respirators (PAPRs) as part of respiratory protection versus another device (N95/FFP2) on HCW infection rates and contamination
Specific practices, or providing recommendations or guidance relating to OR practice, in the context of the COVID-19 pandemic
Powered Air-Purifying Respirator (PAPR) studied separately or within Personal Protective equipment vs. Any other respiratory protective equipment, FFP3/FFP2/N95 or surgical masks
Five domains for data capture were identified a priori: 1) the physical OR factors, 2) personnel factors, 3) patient factors, 4) procedure factors, 5) other considerations.Funding Not applicable Conflicts of interest/Competing interests Not applicable Availability of data and material Not applicable Code availability Not applicable Ethics approval Not applicable
Pre-print medRxiv preprint doi: https://doi.org/10.1101/2022.07.03.22277191; this version posted July 5, 2022. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.June medRxiv preprint doi: https://doi.org/10.1101/2020.04.29.20085175.this version posted May 5, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.Transmission vehicle Mean particle size (diameter) of transmission vehicle Particle suspension time in the air Distance at which the virus can be spread Inoculation site Dose of virus required to induce infection
Aerosol < 5 Œºm in diameter(10,22) However, there is no consensus on the exact size criterion of an aerosol(22) Sufficiently small to remain suspended in air for several minutes or more(10,22) Can be disseminated by air currents throughout a room or facility(10) Lower respiratory tract is thought to be the main inoculation site(8‚àí10) Low doses of virus may be sufficient(8) % of particles of this size emitted during exhalation % of particles of this size emitted during cough or sneeze between 0.5 and < 1 Œºm, and 13% between 1 Œºm and < 5 Œºm(21)2. Increased complacency: for this scenario, we include another behavior change in the model, whereby the relative per-contact probability of transmission increases back to its pre-outbreak value after the 14-day average of new locally-transmitted cases falls below 2. Following the detection of new cases, the probability of someone with symptoms getting tested is assumed to increase as testing capacity is scaled up would result in policy actions comparable to those that have been implemented in the past (i.e., localized school and workplace closures following the detection of more than 5 locally-transmitted cases), but we assume that mask/NPI compliance would not increase again.Table 2. COVID-19 infection rates per 10,000 patient days and vaccine effectiveness between February 1 and October 2, 2021.E [D(41 )] = pd (1 ) ¬∑ N (1 ) ¬∑ P (41 ) + pd (2 ) ¬∑ N (2 ) ¬∑ P (40 ) + ¬∑ ¬∑ ¬∑ + pd (34 ) ¬∑ N (34 ) ¬∑ P (8 )
E [D(42 )] = pd (2 ) ¬∑ N (2 ) ¬∑ P (41 ) + pd (3 ) ¬∑ N (3 ) ¬∑ P (40 ) + ¬∑ ¬∑ ¬∑ + pd (35 ) ¬∑ N (35 ) ¬∑ P (8 ) ..
E [D(103 )] = pd (63 ) ¬∑ N (63 ) ¬∑ P (41 ) + pd (64 ) ¬∑ N (64 ) ¬∑ P (40 )BCG index 2005 (R2 = - 0.66), (C) Life expectancy at birth in 2019 vs. BCG index 2005 (R2 = - 0.79), (D) Hospital beds per 1,000 people, most recent year available since 2010 vs. BCG index 2005 (R2 = - 0.51), (E) Cumulated total number of COVID-19 testing per million (logformation) at day 60 following epidemic start each country vs. cumulated total number of COVID-19 related deaths per million (log-formation) at day 60 (R2 = 0.47), (F) Life expectancy at birth in 2019 vs. cumulated total number of COVID-19 related deaths per million (log-formation) at day 60 following epidemic start each country (R2 = 0.53).266 A systematic review based on experimental designs only found that N95 respirators halve the risk of any respiratory 267 illness compared to surgical masks; the certainty of the evidence was low due to baseline differences, indirectness 268 of evidence for COVID-19, and low event rates that account for imprecision.75 The reduction in contagion risk 269 calculated from 2 RCTs was estimated to be: RR 0.43, 95% CI 0.29, 0.64; I2 = 0%, from pooled analysis; with an 270 absolute effect of preventing 73 (95% CI= 91 - 46) more infections per 1000 HCWs wearing N95 respirators 271 compared with surgical masks.75It seems that almost all of them still follow the way to pay the attention mainly on modelling or forecasting the behavior of spread for epidemic disease directly related to those infected who also become infectious, i.e., the variable ‚ÄúI‚Äù of SEIR modelFactors Associated with Parental Acceptance of COVID-19 Vaccination: A Multicenter Pediatric Emergency Department Cross-sectional Analysis
Brigitte M. Baumann, MD, MSCE, Robert M. Rodriguez, MD, PhD, Amy M. DeLaroche, MBBS, David Rayburn, MD, MPH, Stephanie A. Eucker, MD, PhD, Nicole L. Nadeau, MD, Lisa A. Drago, DO, Danielle Cullen, MD, MPH, Sarah Dennis Meskill, MD, Suzanne Bialeck, MD, Michael Gillman, MD
Please cite this article as: Baumann BM, Rodriguez RM, DeLaroche AM, Rayburn D, Eucker SA, Nadeau NL, Drago LA, Cullen D, Meskill SD, Bialeck S, Gillman M, Factors Associated with Parental Acceptance of COVID-19 Vaccination: A Multicenter Pediatric Emergency Department Cross-sectional Analysis, Annals of Emergency Medicine (2022), doi: https://doi.org/10.1016/ j.annemergmed.2022.01.040.Importance While multiple investigators have documented vaccine hesitancy in adults, little data exists from pediatric populations.13-15 Using an established national internet panel, Szilagyi et al found that less than half of parents are likely to have their child receive a COVID-19 vaccine.10 Yet, telephone and internet-based surveys may miss disadvantaged and highly vulnerable populations ‚Äì those who may be at the greatest risk for morbidity and mortality and who would most benefit from COVID-19 vaccination.6,10,16-20 Furthermore, by focusing only on vaccine hesitancy and not addressing vaccine acceptance, it is possible that important and modifiable factors that can lead to increased vaccine rates may be overlooked.According to the US Office of the Assistant Secretary for Preparedness and Response (ASPR) within the US Department of Health and Human Services (HHS), science preparedness ‚Äúis a collaborative effort to establish and sustain a scientific research framework that can enable emergency planners, responders, and the whole community to better prepare for, respond to, and recover from major public health emergencies and disasters.‚Äù8 Furthermore, in a public health emergency, scientists may need to ‚Äúoperate within a finite window of opportunity to identify, collect, and analyze critical and time-sensitive data that may be available only during the immediacy of the event or incident,‚Äù which highlights the importance of preparedness efforts.8 Recent publications on science preparedness have focused on the need to develop plans (eg, protocols and approvals from Institutional Review Boards) for initiating clinical research during public health emergencies, particularly regarding the inclusion of pregnant women and children in clinical trials of candidate medical countermeasures during outbreaks.9,10 A need also exists, however, to ensure rapid initiation of basic science research during outbreaks of novel or emerging pathogens, particularly with regard to developing new medical countermeasures.However, we shall not take this result very seriously for various reasons, some of which are as follows:
1. although the data is taken during the lock-down period the actual effect of the lock-down is seen later (mostly from April 9), this important contribution of lock-down will be discussed in a later section,
2. some preliminary studies have shown that the virus becomes weaker in hot and humid weather, so the upcoming summer in India and the northern hemisphere will prohibit the spread to a certain extent,
3. some Indian states are doing very well in controlling the spread of the medRxiv preprint doi: https://doi.org/10.1101/2020.05.05.20085902.this version posted May 8, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.Ghosh, Possibilities of exponential or Sigmoid growth of Covid19 data in different states of India, medRxiv:2020.04.10.20060442, 10.13140/RG.2.2.11397.50406 [7] S. Gupta, R. Shankar Estimating the number of COVID-19 infections in Indian hot-spots using fatality data, arXiv:2004.04025 [q-bio.PE] [8] S. Gupta Inferring epidemic parameters for COVID-19 from fatality counts in Mumbai arXiv:2004.11677 [q-bio.PE] [9] S. Mondal, S. Ghosh, Searching the Sigmoid-type trend in Lock Down period covid19 data of India and its different states, 10.13140/RG.2.2.33576.52483 [10] D. Biswas, S. Roy, Analyzing COVID-19 pandemic with a new growth model for population ecology, 10.13140/RG.2.2.34847.92324 [11] A. Bhattacharyya, D. Bhowmik, J. Mukherjee, Forecast and interpretation of daily affected people during 21 days lockdown due to COVID 19 pandemic in India, medarXiv:2020.04.22.20075572 medRxiv preprint doi: https://doi.org/10.1101/2020.05.05.20085902.this version posted May 8, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.Pearson correlation (R) is a statistical measure of goodness of fit between M number of model function values (y) and COVID-19 data (z) as follows [17]: ÔøΩÔøΩÔøΩÔøΩÔøΩÔøΩÔøΩÔøΩÔøΩÔøΩÔøΩÔøΩÔøΩÔøΩÔøΩÔøΩÔøΩÔøΩ1 = ÔøΩÔøΩÔøΩÔøΩÔøΩÔøΩ ÔøΩÔøΩÔøΩÔøΩÔøΩÔøΩ ‚àë ÔøΩÔøΩÔøΩÔøΩÔøΩÔøΩÔøΩÔøΩÔøΩÔøΩÔøΩÔøΩ ‚àí ‚àë ÔøΩÔøΩÔøΩÔøΩÔøΩÔøΩ ‚àë ÔøΩÔøΩÔøΩÔøΩÔøΩÔøΩ = ‚àö(ÔøΩÔøΩÔøΩÔøΩÔøΩÔøΩ ‚àë ÔøΩÔøΩÔøΩÔøΩÔøΩÔøΩ2 ‚àí (‚àë ÔøΩÔøΩÔøΩÔøΩÔøΩÔøΩ)2)(ÔøΩÔøΩÔøΩÔøΩÔøΩÔøΩ ‚àë ÔøΩÔøΩÔøΩÔøΩÔøΩÔøΩ2 ‚àí (‚àë ÔøΩÔøΩÔøΩÔøΩÔøΩÔøΩ)2)
The regression coefficient (R2) is another statistical measure for goodness of fit between M number of projected values (y) and COVID-19 data (z), although we used it as follows [18-19]: = ‚àí =
In equation (15), ÔøΩÔøΩÔøΩÔøΩÔøΩÔøΩÃÖ is the average of COVID-19 data and better fits provide the regression coefficient (R2) values close to unity and Obj2 to zero valueProposition 2.3, we have       œÅ gr S(t )I (t ), S(t )I (t ) ‚â§ œÅ gr S(t )I (t ), S(t )I (t ) + œÅ gr S(t )I (t ), S(t )I (t )       ‚â§ œÅ gr (I (t ), 0ÀÜ (t ))œÅ gr S(t ), S(t ) + œÅ gr S(t ), 0ÀÜ (t ) œÅ gr I (t ), I (t )     ‚â§ Nmax œÅ gr S(t ), S(t ) + Nmax œÅ gr I (t ), I (t ) .To identify, appraise and summarize evidence related to the following questions about public health and health system impacts of the three major SARS-CoV-2 VOC as known in April 2021 (B.1.1.7, B.1.351, and P.1):
1. What is known about the implications of the three priority VOC for public-health measures on: a) Modifying approach to vaccination (e.g., using vaccines that offer greater protection against variants, using different vaccines for first and second doses and/or re-vaccinating those initially vaccinated with vaccines with limited efficacy for new strains) b) Modifying infection-prevention (i.e., public-health) measures in the community (e.g., changing duration of hand washing; changing mask type and characteristics, double masking, or other changes to masking; and changes to physical and temporal distancing) c) Modifying infection-control procedures, such as: ‚ñ™ Changing duration for quarantining of exposed or potentially exposed individuals ‚ñ™ Changing duration for isolating suspected or confirmed cases (e.g., for exposed health workers) ‚ñ™ Changing testing strategy, including approach to testing, frequency of testing, and turn-around time for test results ‚ñ™ Changing approach to contact tracing ‚ñ™ Changing approach to outbreak management m(ewd2hR.ixcihv pwWraesphrnianotttdciosei:rhtkitfntipeosd:/wb/dynoip.oearegbr/1or0eu.v1it1e0wth1)/ei2s0t2ihm1e.0ap5u.lt2ihc0o.ar2/f1tui2no5dn7e5rs,1w7o;htfohithshavesegrstrihaonnrteepdoesmtpeeddrRiMoxarivyita2y2li,cV2e0nO2se1C.toTfhdoeisrcpolhapyeyrtaihgehlttphhreospldryiensrt ftionerpmtheirspeptrueiptyr.int arrangement (parIttiiscmualaderlayvafiolarblehuonsdepriataClCs-)BYo-nN:C-ND 4.0 International license ABM: Agent-based Model AGREE II: Appraisal of Guidelines Research and Evaluation aIRR: adjusted incidence rate ratios B.1.1.7: variant of concern originating in the United Kingdom, also known as VUI 202012/01 and VOC 202012/01 B.1.351: variant of concern originating in South Africa, also known as 20H/501Y.V2 BMI: body mass index CanCOGen: Canadian COVID Genomics Network CENTRAL: Central Register of Controlled Trials CFR: Case Fatality Rates CI: confidence interval CIDRAP: Center for Infectious Disease Research and Policy Ct: cycle threshold, provides a relative measure of viral quantity COG-UK: COVID-19 Genomics UK CDSR: Cochrane Database of Systematic Reviews dQALY: discounted quality-adjusted life years E484K: escape mutation in the SARS-CoV-2 virus, present in B.1.1.7 ECDC: European Centres for Disease Control FDA: Food and Drug Administration HCW: healthcare workers HR: Hazard Ratio HVAC: heating, ventilation, and air conditioning ICU: Intensive Care Unit IQR: interquartile range IR: incidence rate LOS: length of stay mRNA: messenger ribonucleic acid NGS: next generation sequencing NOS: Newcastle-Ottawa scale NPI: Non-Pharmaceutical Interventions NRW: North-Rhine Westphalia OR: odds ratio P.1: variant of concern originating in Brazil, also known as B.1.28.1 PCR: polymerase chain reaction, method for DNA replication and genome sequencing PHU: Public Health Unit PPE: personal protective equipment PR: prevalence ratio R: reproduction R0: basic reproduction number, expected number of cases generated by one case in a population when everyone is susceptible to infection Rt: effective reproduction number iv medRxiv preprint doi: https://doi.org/10.1101/2021.05.20.21257517; this version posted May 22, 2021141 We model a vaccine that reduces symptomatic infection by 90% (approximately in line with vac-
142 cine efficacy of the Pfizer and Moderna mRNA vaccines) in two ways: 1) by reducing infection but
143 not impacting disease progression (V Esusceptibility = 0.9, V Einfectiousness = 0, V Eprogression = 0),
144 hereafter referred to as ‚Äòsusceptibility-only vaccine‚Äô or by 2) reducing both infection and the prob-
145 ability of symptoms given infection (V Esusceptibility = 0.67, V Einfectiousness = 0, V Eprogression =
146 0.70), hereafter referred to as a ‚Äôsusceptibility and severity vaccine.‚Äô These quantities were chosen
147 so that the observed impact on symptomatic disease is the same (i.e., (1 ‚àí V Esusceptibility) √ó (1 ‚àí
